Assembly Biosciences (NASDAQ:ASMB) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.65) by 69.23 percent. This is a 84.96 percent increase over losses of $(1.33) per share from the same period last year. The company reported quarterly sales of $13.374 million which beat the analyst consensus estimate of $8.599 million by 55.53 percent. This is a 38.94 percent increase over sales of $9.626 million the same period last year.